US Patent 8333978 Poly TLR antagonist
Patent 8333978 was granted and assigned to Cadila Pharmaceuticals on December, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08333978 Poly TLR antagonist US Patent 8333978 Poly TLR antagonist
Infobox
Patent Number
0833397800
Patent Number
833397800
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083339780
Date of Patent
December 18, 2012
0Patent Application Number
122956970
Date Filed
November 21, 2007
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083339780
Date of Patent
December 18, 2012
0Patent Application Number
122956970
Date Filed
November 21, 2007
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08333978 Poly TLR antagonist
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08333978
Date of patent
December 18, 2012
Patent application number
12295697
Date Filed
November 21, 2007
Patent primary examiner
Find more entities like US Patent 8333978 Poly TLR antagonist
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.